u/discount_math_dm

sponsor and disclosure questions are always answered publicly

I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.

telehealth prescriber models exist, pricing differs by state

saved.

Adding to this: ATTAIN is doing more work than the comment implies.

phase 2 numbers are not maintenance numbers, cite the trial

The telehealth + compounding combo cost telehealth plus 20% markup. Not cheap but covered by insurance depending on state.

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

Strongly agree. The supply impact would be huge.

Not to be pedantic but shortage list and 503A are being used interchangeably and they are not interchangeable in real life.

Which network and did the vendor confirm they credit it?

This is correct. Modmail first.

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

The discount was 97.4% but gas ate half of it. Still worth it but the math matters.

[removed by moderator]

Disagree on that part. 98.7% and 96.2% on the same vial is normal.

Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.

The confident tone is doing a lot of work that the evidence is not.

the appetite change on tirz is more than just reduced hunger, it is different machinery

API transparency is the question that separates good compounders from sketchy ones

Yes, exactly this, and it is the bit that took me 92 weeks to accept.

the GIP side does different things than the GLP-1 side, that is the point

no price talk, no tickers, no investment discussion